Form D/A — Gut-Brain-Axis Therapeutics Inc.
0001996678-26-000001 · filed Oct 27, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Reported offering amount
- $20,000,000
- Reported amount sold
- $1,965,000
- Minimum investment
- $0
- Investors
- 22
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Gut-Brain-Axis Therapeutics Inc.
- CIK
- 1996678
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 1340 E VINEDO LANE
TEMPE, AZ 85284 - Phone
- (480) 818-0741
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
James B. Adams · Executive OfficerTempe, AZ Find on LinkedIn ↗
-
Alexander Khoruts · DirectorTempe, AZ Find on LinkedIn ↗
-
Rosa Krajmalnik-Brown · DirectorTempe, AZ Find on LinkedIn ↗
-
Michael J. Sadowsky · DirectorTempe, AZ Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗